AIDS related systemic non-Hodgkin's lymphoma

Sexually Transmitted Infections

Volumn 76, Issue 5, 2000, Pages 335-341

  Powles, T ^a   Matthews, G ^a   Bower, M ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

AIDS; HIV; Non Hodgkin's lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; B CELL LYMPHOMA; CHEMOTHERAPY; CLINICAL FEATURE; DISEASE ASSOCIATION; EUROPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOCOMPETENCE; INCIDENCE; MEDICAL INFORMATION; MOLECULAR GENETICS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, B-CELL; LYMPHOMA, HIGH-GRADE; MALE; PROGNOSIS; REMISSION INDUCTION;

EID: 0033768887     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.76.5.335     Document Type: Article

References (72)

1. Cancers complicating organ transplantation
2. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value
3. NonHodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome
4. AIDS-associated non-Hodgkin lymphoma
5. Surveillance for AIDS defining opportunistic illnesses 1992-1997
6. Spectrum of AIDS-associated malignant disorders
7. Advances in the epidemiology of HIV-associated Non-Hodgkin's lymphoma and other lymphoid neoplasms
8. Disease progression and survival following specific AIDS-defining conditions: A retrospective cohort study of 2048 HIV-infected persons in London
9. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: The changing face of AIDS
10. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
11. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group
12. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study
13. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence and trends in AIDS Clinical Trial Group study participants
14. Combination antiretroviral therapy and incidence of AIDS-related malignancy
15. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma among HIV-1 infected individuals
16. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): The New York University Medical Center experience with 109 patients
17. AIDS-related lymphoid neoplasia. The Memorial Hospital Experience
18. HIV-associated non-Hodgkin's lymphomas: Clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumours
19. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: A comparative study
20. Anatomic and histologic distribution of 448 cases of AIDS-related non Hodgkin's lymphoma. Proceedings of the annual meeting of the American Society of Hematology
21. Acquired immunodeficiency syndrome-associated lymphomas: Clinical, pathologic, immunologic, and viral characteristics of 111 cases
22. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
23. Multicentric Castleman's disease in HIV infection: A clinical and pathological study of 20 patients
24. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma
25. Direct polyclonal activation of human B lymphocytes by the AIDS virus
26. Induction of IL-6 production by human immunodeficiency virus
27. Interleukin-6 production in high grade lymphoma: Correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus seronegative patients
28. Interleukin 10 is an autocrine growth factor for AIDS-related B cell lymphoma
29. Patterns of cytokine expression in AIDS-related non-Hodgkin's lymphoma
30. Expression of Epstein-Barr virus latent genes and adhesion molecules in AIDS-related non-Hodgkin's lymphoma: Correlation with histology and CD4 cell number
31. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease
32. Specific translocations characterize Burkitt-like lymphoma in homosexual men with the acquired immunodeficiency syndrome
33. Frequent c-myc oncogene activation and infrequent presence of Epstein Barr virus genome in AIDS-associated lymphoma
34. Pathogenesis of AIDS-related lymphomas: Molecular and histiogenetic heterogeneity
35. Rearrangement of the Bcl-6 gene in AIDS-associated non-Hodgkin's lymphoma
36. Frequent mutation of the 5' noncoding region of the bcl-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas
37. BCL-6 in AIDS-related lymphomas: Pathogenetic and histogenetic implications
38. Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation
39. Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus 1 infected individuals
40. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply exposed individuals to HIV-1 infection
41. Resistance to HIV-1 infection in caucasian individuals bearing mutnant alleles of the CCR-5 chemokine receptor gene
42. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion of the CKR5 structural gene
43. Immunoglobulin secreted by an AIDS lymphoma cell line recognises HIV gp160, suggesting that the immune response to HIV antigens may contribute to lymphomagenesis
44. Acquired immunodeficiency syndrome-associated T-cell lymphoma: Evidence for human immunodeficiency virus type 1-associated T-cell transformation
45. Epidemiology of HIV associated NHL
46. Acquired immunodeficiency syndrome-related lymphoma
47. Lymphoma: An opportunistic neoplasm of AIDS
48. Results using chemotherapv in AIDS patients with hepatic non-Hodgkin's lymphoma (HNHL)
49. Clinical immunological and pathological correlates of bone marrow involvement in 253 patients with AIDS-related lymphoma
50. Low dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma
51. AIDS-associated non-Hodgkin's lymphoma
52. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma
53. AIDS-associated non-Hodgkin's lymphoma in San Francisco
54. Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival
55. A predictive model for aggressive non-Hodgkin's lymphoma
56. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: Analysis of AIDS Clinical Trials Group protocol 142-low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases
57. Long-term survival of patients with HIV-related systemic non-Hodgkin's lymphomas
58. Age and serum lactate dehydrogenase level are indepedent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: A single-institute study of 96 patients
59. Randomized trial of standard dose mBACOD with GM-CSF vs reduced dose mBACOD for systemic HIV-associated lymphoma: ACTG 142
60. Low dose compared with standard dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection
61. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group
62. Novel oral combination chemotherapy in the treatment of intermediate grade and high grade AIDS-related non-Hodgkin's lymphoma
63. Weekly alternating combination chemotherapy for good prognosis AIDS related lymphoma
64. Pilot trial of infusional cyclophosphamide, doxorubicin and etoposide plus didanosine and filgrastim in patients with HIV associated non-Hodgkin's lymphoma
65. Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin and etoposide in patients with HIV-associated non-Hodgkin's lymphoma
66. Phase II trial of infusional cyclophosphamide, doxorubicin and etoposide (CDE) in HIV-associated non-Hodgkin's lymphoma: An Eastern Cooperative Oncology Group trial (E1494)
67. Dose-adjusted EPOCH chemotherapy in previously untreated HIV-associated non-Hodgkin's lymphoma
68. Mitoguazone (MGBG) with radiation therapy in AIDS-related primary CNS-lymphoma
69. Treatment of AIDS-lymphomas with an anti-IL-6 monoclonal antibody
70. Anti-B4 (CD19) monoclonal antibody conjugated with ricin (B4-blocked ricin) in refractory AIDS-lymphoma
71. Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma
72. Rituximab for the treatment of AIDS-associated non-Hodgkin's lymphoma